LGALS3 and chronic kidney disease: Higher circulating levels of galectin-3 have been associated with a higher risk of incident CKD and decline in renal function, suggesting that levels of galectin-3 can be used to predict kidney injury years before CKD is detected clinically, allowing for the early provision of targeted treatment and disease prevention.